Inactive Instrument

Highlights Standard BioTools Inc.

Equities

SLGC

US83444K1051

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Somalogic, Inc. Provides Revenue Guidance for Fourth Quarter and Full Year 2023	Jan. 08	CI
Standard BioTools Says Merger With SomaLogic Completed	Jan. 05	MT
SomaLogic, Standard BioTools Receive Shareholder Approvals for Pending Merger	Jan. 05	MT
Madryn Asset Addresses SomaLogic?s Failure to Obtain Requisite Shareholder Support for the Proposed Merger with Standard BioTools	Jan. 04	CI
Egan-Jones Recommends SomaLogic Shareholders Vote Against Proposed Merger with Standard BioTools	Jan. 03	CI
Boston Millennia Partners Intends to Vote Against Proposed Merger with Standard BioTools Inc.	Dec. 31	CI
Glass Lewis and ISS Recommends SomaLogic Stockholders to Vote for Proposed Merger	Dec. 29	CI
Glass Lewis and ISS Recommends SomaLogic Stockholders to Vote for Proposed Merger	Dec. 29	CI
Glass Lewis and ISS Recommends SomaLogic Stockholders to Vote for Proposed Merger	Dec. 29	CI
SomaLogic Says Madryn Asset Management's Statement on SomaLogic-Standard BioTools Merger Misleading	Dec. 27	MT
Madryn Asset Management Sends Letter to Institutional Shareholder Services Requesting it Withdraw Support for SomaLogic?s Proposed Merger with Standard BioTools	Dec. 26	CI
Madryn Asset Management Reiterates Alternative Path to SomaLogic?s Value-Destructive Proposed Merger with Standard BioTools	Dec. 26	CI
ISS Recommends SomaLogic Stockholders to Vote for Proposed Merger	Dec. 22	CI
ISS Recommends SomaLogic Stockholders to Vote for Proposed Merger	Dec. 22	CI
ISS Recommends SomaLogic Stockholders to Vote for Proposed Merger	Dec. 22	CI
Tikvah Management Announces Intention to Vote Against Proposed Merger	Dec. 22	CI
SomaLogic Recommends Shareholders to Vote For its Merger with Standard BioTools	Dec. 19	CI
Madryn Asset Management Issues Letter Regarding Opposition to SomaLogic?s Proposed Merger with Standard BioTools	Dec. 13	CI
SomaLogic, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 08	CI
Earnings Flash (SLGC) SOMALOGIC Reports Q3 Revenue $22M, vs. Street Est of $20.3M	Nov. 08	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Standard BioTools Inc.

Equities

SLGC

US83444K1051

Highlights

Filters